BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18197460)

  • 1. Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues.
    Lens M; Bataille V
    Cancer Causes Control; 2008 Jun; 19(5):437-42. PubMed ID: 18197460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis.
    Gandini S; Iodice S; Koomen E; Di Pietro A; Sera F; Caini S
    Eur J Cancer; 2011 Nov; 47(17):2607-17. PubMed ID: 21620689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do hormones influence melanoma? Facts and controversies.
    Gupta A; Driscoll MS
    Clin Dermatol; 2010; 28(3):287-92. PubMed ID: 20541681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous melanoma in relation to exogenous hormones and reproductive factors.
    Holly EA; Weiss NS; Liff JM
    J Natl Cancer Inst; 1983 May; 70(5):827-31. PubMed ID: 6573527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy history and incidence of melanoma in women: a pooled analysis.
    Karagas MR; Zens MS; Stukel TA; Swerdlow AJ; Rosso S; Osterlind A; Mack T; Kirkpatrick C; Holly EA; Green A; Gallagher R; Elwood JM; Armstrong BK
    Cancer Causes Control; 2006 Feb; 17(1):11-9. PubMed ID: 16411048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal melanoma, hormonal and reproductive factors in women.
    Holly EA; Aston DA; Ahn DK; Kristiansen JJ; Char DH
    Cancer Res; 1991 Mar; 51(5):1370-2. PubMed ID: 1997174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pregnancy, hormone preparations and malignant melanoma].
    Garbe C
    Hautarzt; 1993 Jun; 44(6):347-52. PubMed ID: 8335457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy.
    Naldi L; Altieri A; Imberti GL; Giordano L; Gallus S; La Vecchia C;
    Ann Epidemiol; 2005 Aug; 15(7):545-50. PubMed ID: 16029848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parity and decreased use of oral contraceptives as predictors of asthma in young women.
    Jenkins MA; Dharmage SC; Flander LB; Douglass JA; Ugoni AM; Carlin JB; Sawyer SM; Giles GG; Hopper JL
    Clin Exp Allergy; 2006 May; 36(5):609-13. PubMed ID: 16650045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women.
    Osterlind A; Tucker MA; Stone BJ; Jensen OM
    Int J Cancer; 1988 Dec; 42(6):821-4. PubMed ID: 3192324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does use of estrogens decrease the Breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy.
    Koomen ER; Joosse A; Herings RM; Casparie MK; Guchelaar HJ; Nijsten T
    Melanoma Res; 2009 Oct; 19(5):327-32. PubMed ID: 19593232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal choices after gestational diabetes. Subsequent pregnancy, contraception, and hormone replacement.
    Kjos SL; Peters RK; Xiang A; Schaefer U; Buchanan TA
    Diabetes Care; 1998 Aug; 21 Suppl 2():B50-7. PubMed ID: 9704227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy and ovulation inhibitors as risk factors in malignant melanoma].
    Zaun H
    Hautarzt; 1983 Dec; 34(12):593-5. PubMed ID: 6662722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive history and cutaneous malignant melanoma: a comparison between women and men.
    Kaae J; Andersen A; Boyd HA; Wohlfahrt J; Melbye M
    Am J Epidemiol; 2007 Jun; 165(11):1265-70. PubMed ID: 17327217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of parity, oral contraceptive use and hormone replacement therapy on the incidence of varicose veins.
    Jukkola TM; Mäkivaara LA; Luukkaala T; Hakama M; Laurikka J
    J Obstet Gynaecol; 2006 Jul; 26(5):448-51. PubMed ID: 16846875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma and pregnancy.
    Driscoll MS; Grant-Kels JM
    G Ital Dermatol Venereol; 2008 Aug; 143(4):251-7. PubMed ID: 18833081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pregnancy on survival in women with cutaneous malignant melanoma.
    Lens MB; Rosdahl I; Ahlbom A; Farahmand BY; Synnerstad I; Boeryd B; Newton Bishop JA
    J Clin Oncol; 2004 Nov; 22(21):4369-75. PubMed ID: 15514378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive risk factors for cutaneous melanoma in women: a case-control study.
    Lea CS; Holly EA; Hartge P; Lee JS; Guerry D; Elder DE; Halpern A; Sagebiel RW; Tucker MA
    Am J Epidemiol; 2007 Mar; 165(5):505-13. PubMed ID: 17158470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.